The EUROpean Treatment & Reduction of Acute Coronary Syndromes cost analysis
The EUROTRACS project’s main objective consisted of utility analysis (cost-effectiveness) in terms of cost per Quality-Adjusted Life Years (QALY) in the following:
- Three interventions designed to prevent coronary artery disease incidence aimed at reducing: smoking, dyslipidemia, and hypertension population prevalence;
- The optimal use of coronary angiography and percutaneous intervention procedures in the management of patients with acute coronary syndrome.
The proposed action sought to give policymakers recommendations for the design of national and international public health actions aimed at decreasing coronary artery disease (CAD) morbidity and mortality in the most cost-efficient manner.
The EUROTRACS project was funded by the Executive Agency for Health and Consumers entrusted by the European Commission to implement the Health Programme (2008-2013). EUROTRACS contributed to the EU Health Programme’s main objective “to promote health, including the reduction of health inequalities.”
EUROTRACS concluded in 2015.